Back to Authors

Daffner, Kirk R.

https://orcid.org/0000-0002-5063-2247

A5028353181 | I1282516798

Mayo Clinic

Atrium Health Wake Forest Baptist

Citations 5

Antiamyloid Monoclonal Antibodies in Alzheimer’s Disease, Part 2: Challenges in Dementia Care Delivery System Logistics

The Journal of Neuropsychiatry and Clinical Neurosciences | June 26, 2025 | Volume: 37 | Issue: 4 | Pages: 378-384

10.1176/appi.neuropsych.20240203 | PMID 40566858

Antiamyloid Monoclonal Antibodies in Alzheimer’s Disease, Part 1: Patient Selection

The Journal of Neuropsychiatry and Clinical Neurosciences | May 5, 2025 | Volume: 37 | Issue: 4 | Pages: 371-377

10.1176/appi.neuropsych.20240191 | PMID 40320852

Promoting Growth in Behavioral Neurology: A Path Forward

Cognitive and Behavioral Neurology | May 8, 2024 | Volume: 37 | Issue: 2 | Pages: 49-56

10.1097/wnn.0000000000000368 | PMID 38717325

Behavioral neurology & neuropsychiatry (BNNP) is a field that seeks to understand brain–behavior relationships, including fundamental brain organization principles and the many ways that brain structures and connectivity can be disrupted, leading to abnormalities of behavior, cognition, emotion, perception, and social cognition. In North America, BNNP has existed as an integrated subspecialty through the United Council for Neurologic Subspecialties since 2006. Nonetheless, the number of behavioral neurologists across academic medical centers and community settings is not keeping pace with increasing clinical and research demand. In this commentary, we provide a brief history of BNNP followed by an outline of the current challenges and opportunities for BNNP from the behavioral neurologist’s perspective across clinical, research, and educational spheres. We provide a practical guide for promoting BNNP and addressing the shortage of behavioral neurologists to facilitate the continued growth and development of the subspecialty. We also urge a greater commitment to recruit trainees from diverse backgrounds so as to dismantle persistent obstacles that hinder inclusivity in BNNP—efforts that will further enhance the growth and impact of the subspecialty. With rapidly expanding diagnostic and therapeutic approaches across a range of conditions at the intersection of neurology and psychiatry, BNNP is well positioned to attract new trainees and expand its reach across clinical, research, and educational activities.
Do We Practice What We Preach Regarding Clinical Cognitive Testing?: Results From an AAN Behavioral Neurology Section Survey (S18.003)

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.s18.003

Improving clinical cognitive testing

Neurology | July 11, 2015 | Volume: 85 | Issue: 10 | Pages: 910-918

10.1212/wnl.0000000000001763 | PMID 26163433